Search

Author/Creator Button, Tom

1. Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy. Issue 2 (21st May 2014)

Authors:
Tuohy, Orla; Costelloe, Lisa; Hill-Cawthorne, Grant; Bjornson, Ingunn; Harding, Katharine; Robertson, Neil; May, Karen; Button, Tom; Azzopardi, Laura; Kousin-Ezewu, Onajite; Fahey, Michael T; Jones, Joanne; Compston, D Alastair S; Coles, Alasdair
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 86:Issue 2(2015)
Page Start:
208
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis. Issue 3 (5th November 2011)

Authors:
Hill-Cawthorne, Grant A; Button, Tom; Tuohy, Orla; Jones, Joanne L; May, Karen; Somerfield, Jennifer; Green, Alison; Giovannoni, Gavin; Compston, D Alastair S; Fahey, Michael T; Coles, Alasdair J
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 83:Issue 3(2012)
Page Start:
298
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumab. (August 2020)

Authors:
Brown, J William L; Prados Carrasco, Ferran; Eshaghi, Arman; Sudre, Carole H; Button, Tom; Pardini, Matteo; Samson, Rebecca S; Ourselin, Sebastien; Wheeler-Kingshott, Claudia AM Gandini; Jones, Joanne L; Coles, Alasdair J; Chard, Declan T
Journal:
Multiple sclerosis
Issue:
Volume 26:Number 9(2020)
Page Start:
1093
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗